Patent · US Active

Organic compositions to treat HSF1-related diseases

US9540643B2 · kind B2 · utility

2Cited by

14References

21Claims

0Family size

Assignee

Arrowhead Pharmaceuticals, Inc. · US

Inventors

Gregory Hinkle · Plymouth, US
Satyanarayana Kuchimanchi · Cambridge, US
Stuart Milstein · Cambridge, US
Markus Warmuth · Natick, US
Wenlai Zhou · Cambridge, US
Ping Zhu · Boxborough, US
Tracy Zimmermann · Cambridge, US

Key dates

Filing date	Jun 22, 2015
Grant date	Jan 10, 2017
Priority date	—
Expiry date	Jun 22, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.